Charles Swindell | CEO, Glycotest – Advancing Glycoprotein Biomarkers for Liver Disease Detection

from Executive Insights for Life Sciences Innovators · host GeneCoda® Executive Search

In this episode of Executive Insights for Life Sciences Innovators, we speak with Charles Swindell, CEO of Glycotest, about the company’s proprietary technology that measures glycoprotein fucosylation for the detection of liver diseases. Charles shares insights on the science behind Glycotest’s platform, the challenges of bringing diagnostic innovation to market, and the future of precision liver disease detection.Learn more at genecoda.com.Originally recorded and streamed on YouTube Live on March 14, 2025.

Episode metadata supplied by the publisher feed · Published Sep 8, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Charles Swindell | CEO, Glycotest – Advancing Glycoprotein Biomarkers for Liver Disease Detection

0:00 28:43

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Executive Insights for Life Sciences Innovators?

This episode is 28 minutes long.

When was this Executive Insights for Life Sciences Innovators episode published?

This episode was published on September 8, 2025.

Can I download this Executive Insights for Life Sciences Innovators episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!